Filter
3701
Filtered Results: 3701
Text search:
drug
abuse
Featured
Recommendations
351
New Publications
962
Language
Document type
No document type
2408
Studies & Reports
495
Guidelines
430
Manuals
142
Strategic & Response Plan
100
Fact sheets
44
Training Material
39
Situation Updates
16
Brochures
11
Resource Platforms
7
Infographics
7
Dashboards/Maps
1
Videos
1
Countries / Regions
India
240
Kenya
112
Global
102
South Africa
100
Ethiopia
90
Western and Central Europe
85
Uganda
76
Nigeria
74
Liberia
64
Tanzania
62
Zambia
57
Myanmar / Burma
56
Malawi
55
Nepal
54
Sierra Leone
54
Bangladesh
49
Ghana
48
Africa
48
Ukraine
47
Latin America and the Carribbean
41
Eastern Europe
39
Namibia
36
Philippines
33
Rwanda
31
Asia
31
Russia
29
Lesotho
28
South–East Asia Region
28
Zimbabwe
25
Cambodia
22
Indonesia
22
Botswana
21
Syria
20
Eswatini/ Swaziland
19
Congo, Democratic Republic of
18
Germany
15
USA
14
Senegal
12
Burkina Faso
12
Venezuela
10
West and Central Africa
10
Middle East and North Africa
10
South Sudan
10
Cameroon
9
Mozambique
9
Haiti
9
Eastern Europe and Central Asia
9
East and Southern Africa
9
Georgia
9
Pakistan
9
Tajikistan
8
Colombia
8
Albania
8
Thailand
7
Brazil
7
Sudan
7
Afghanistan
6
Yemen
6
North Macedonia
5
Mexico
5
China
5
Guinea
5
Western Pacific Region
5
Vietnam
5
Somalia
5
Armenia
4
United Kingdom
4
Argentina
4
Lebanon
4
Moldova
4
Sri Lanka
4
Central African Republic
4
Bhutan
4
Iraq
4
Laos
3
Jordan
3
Paraguay
3
Jamaica
3
Belarus
3
Southern Africa
3
Papua New Guinea
3
Palestine
3
Madagascar
3
Timor Leste/ East Timor
2
El Salvador
2
Turkey
2
Benin
2
Kazakhstan
2
Iran
2
Canada
2
Kyrgyzstan
2
Uzbekistan
2
Peru
2
Morocco
2
Hungary
2
Saudi Arabia
2
Tunisia
2
Portugal
2
Côte d’Ivoire / Ivory Coast
2
Mali
2
Libya
2
North Korea
1
Serbia
1
Australia
1
Gambia
1
Chile
1
Fiji
1
Singapore
1
Estonia
1
Malaysia
1
Qatar
1
Bulgaria
1
Italy
1
Lithuania
1
Ireland
1
North America
1
Gabon
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Norway
1
Spain
1
Djibouti
1
Egypt
1
Greece
1
Poland
1
Angola
1
Chad
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
1398
Clinical Guidelines
347
Public Health
188
Women & Child Health
157
Capacity Building
59
Key Resources
56
Pharmacy & Technologies
42
Toolboxes
Mental Health
595
HIV
417
TB
277
COVID-19
150
AMR
133
NCDs
95
NTDs
89
Pharmacy
83
Caregiver
63
Refugee
59
Disability
59
Rapid Response
55
Ebola
44
Conflict
42
Global Health Education
38
Planetary Health
37
Health Financing Toolbox
20
Natural Hazards
17
Social Ethics
15
Polio
13
Specific Hazards
10
Cholera
10
Zika
9
Health Financing
1
Climate change threatens to undermine the past 50 years of gains in public health. In response, theNational Health Service (NHS) in England has been working since 2008 to quantify and reduce its carbon footprint.
This Article presents the latest update to its greenhouse gas accounting, identifying ...
Antimicrobial resistance (AMR) has emerged as a major public health concern, around which the international leadership has come together to form strategic partnerships and action plans. The main driving force behind the emergence of AMR is selection pressure created due to consumption of antibiotics...
Front. Public Health, 30 April 2021 | https://doi.org/10.3389/fpubh.2021.628744
The authors conduct an integrated survey of Antimicrobial Resistant Organisms (AMR) in drinking water, wastewater and surface water in three settings in Bangladesh: rural households, rural poultry farms, and urban food markets. Results show that untreated water discharged from rural households, poul...
Tuberculosis continues to represent a severe public health problem in the Region of the Americas, even more so in the case of indigenous peoples, whose TB incidence is much higher than that of the general population. To achieve tuberculosis control in these communities, it is necessary to respond t...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
Tis first edition describes the standard operating procedures for health products for NTDs amenable to preventive chemotherapy and the medicines donated to treat them. These include albendazole for lymphatic filariasis and soil-transmitted helminthiases; azithromycin for trachoma and yaws; diethylca...
Responding to Outbreaks of Antimicrobial-resistant Pathogens in Health-care Facilities: Guidance for the Western Pacific Region is developed following requests from Member States in the Western Pacific Region for additional information and support in managing AMR outbreaks. It aims to provide: a ste...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
Government of Nepal has an obligation to ensure availability of affordable and high quality basic health care services to its population
This policy brief aims to provide a review of the current progress on implementing the Kenya national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing ac...
In 1997, the Fiftieth World Health Assembly adopted resolution WHA50.29 on the elimination of
lymphatic filariasis as a public health problem. Preliminary guidance from WHO printed in 2011 referred to “verification” as the official process by which the achievements of the Global Programme to El...
Meeting of the Neglected Tropical Diseases Strategic and Technical Advisory
Group’s Monitoring and Evaluation Subgroup on Disease-specific Indicators
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da...
International commitment to eliminate trachoma as a public health problem worldwide is supported by resolution WHA51.11 of the World Health Assembly .1 Important progress towards this goal has been made by harnessing the mostly informal relationships that exist between partners including Member Stat...
SECOND MEETING REPORT
DECATUR, GA, USA, 26 JUNE 2016
Not long ago, on the occasion of the 100th anniversary of the discovery of Chagas disease, several campaigns denounced the scant progress has been made in diffrent spheres- medical, scientific and politcal- but major challanges still remain. This is an appropriate time to celebrate what has been ach...
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via consumption of food or drink contaminated by triatomi...
Trachoma, caused by particular serovars of Chlamydia trachomatis, is the leading
infectious cause of blindness. Infection is transmitted within ocular and nasal secretions that are passed from person to person on fingers, fomites (such as clothing) and eye-seeking flies (particularly Musca sorbens)...
